These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20173328)
1. Acetylcholinesterase variants in Alzheimer's disease: from neuroprotection to programmed cell death. Greenberg DS; Toiber D; Berson A; Soreq H Neurodegener Dis; 2010; 7(1-3):60-3. PubMed ID: 20173328 [TBL] [Abstract][Full Text] [Related]
2. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160 [TBL] [Abstract][Full Text] [Related]
3. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease. Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395 [TBL] [Abstract][Full Text] [Related]
4. The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines. Hicks DA; Makova NZ; Gough M; Parkin ET; Nalivaeva NN; Turner AJ J Biol Chem; 2013 Sep; 288(36):26039-26051. PubMed ID: 23897820 [TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients. Campanari ML; Navarrete F; Ginsberg SD; Manzanares J; Sáez-Valero J; García-Ayllón MS J Alzheimers Dis; 2016 May; 53(3):831-41. PubMed ID: 27258420 [TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease. Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463 [TBL] [Abstract][Full Text] [Related]
7. Discovering and targeting the basic mechanism of neurodegeneration: the role of peptides from the C-terminus of acetylcholinesterase: non-hydrolytic effects of ache: the actions of peptides derived from the C-terminal and their relevance to neurodegeneration. Greenfield S Chem Biol Interact; 2013 May; 203(3):543-6. PubMed ID: 23562497 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Yang L; He HY; Zhang XJ Neurosci Res; 2002 Apr; 42(4):261-8. PubMed ID: 11985878 [TBL] [Abstract][Full Text] [Related]
14. Cellular stress reactions as putative cholinergic links in Alzheimer's disease. Toiber D; Soreq H Neurochem Res; 2005; 30(6-7):909-19. PubMed ID: 16187225 [TBL] [Abstract][Full Text] [Related]
15. The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers. Cottingham MG; Voskuil JL; Vaux DJ Biochemistry; 2003 Sep; 42(36):10863-73. PubMed ID: 12962511 [TBL] [Abstract][Full Text] [Related]
16. Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Nijholt I; Farchi N; Kye M; Sklan EH; Shoham S; Verbeure B; Owen D; Hochner B; Spiess J; Soreq H; Blank T Mol Psychiatry; 2004 Feb; 9(2):174-83. PubMed ID: 14581933 [TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554 [TBL] [Abstract][Full Text] [Related]
18. It all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease. Berson A; Soreq H Rambam Maimonides Med J; 2010 Oct; 1(2):e0014. PubMed ID: 23908786 [TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of TAT-haFGF(₁₄₋₁₅₄) attenuates disease progression in a mouse model of Alzheimer's disease. Lou G; Zhang Q; Xiao F; Xiang Q; Su Z; Zhang L; Yang P; Yang Y; Zheng Q; Huang Y Neuroscience; 2012 Oct; 223():225-37. PubMed ID: 22885230 [TBL] [Abstract][Full Text] [Related]
20. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]